AVLYNMOX-CL 625

AVLYNMOX-CL 625

Amoxycillin Trihydrate 500 mg + Potassium Clavulanate 125 mg


Composition

Amoxycillin Trihydrate 500 mg + Potassium Clavulanate 125 mg


Category

Beta-lactam Antibiotic + Beta-lactamase Inhibitor


Indications

Respiratory Tract Infections:

  • Ear, Nose & Throat (ENT) Infections
  • Bronchitis, pneumonia, sinusitis
  • Otitis media, tonsillitis, pharyngitis
  • Urinary Tract Infections (UTIs)
  • Skin & Soft Tissue Infections
  • Dental Infections

Key Advantages

  • Combination therapy enhances efficacy
  • Well-tolerated and safe for all age groups
  • Convenient dosing improves patient compliance
  • Broad-spectrum activity against resistant bacteria